conventional doses of warfarin to prevent recurrent venous thromboembolism

Experts will be sticking with conventional doses of warfarin to prevent recurrent venous thromboembolism.

For a while, it looked like the trend was going towards "low-intensity warfarin" for long-term prophylaxis.

It was hoped that titrating to a lower INR of 1.5 to 2.0 would be as effective and cause less bleeding than the usual INR target of 2.0 to 3.0.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote